From the Ottawa Citizen:
A lobbyist with past ties to Prime Minister Stephen Harper was retained last month by the drug company that stands to benefit from a newly announced $300 million in federal funding for a vaccination program to prevent cervical cancer.
Ken Boessenkool, who served as Mr. Harper's senior policy adviser until 2004, registered to lobby the federal government on immunization policy on behalf of Merck Frosst Canada. ...more
Links to the latest news in the world of pharmacy with a focus on items most relevant to Canadian pharmacists or others that are interested in Canadian pharmacies. This includes news about Canadian pharmacy seen in the mainstream media on topics such as new drug information and the international pharmacy industry.
Friday, March 23, 2007
Former Harper adviser lobbying for drug firm
I'm glad the HPV vaccination program cash was included in this week's budget. However, it's really bad optics when a senior PM advisor just started to work for the only company that can benefit from the program.
No comments:
Post a Comment